Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Walking Capacity in PAD
NCT02832570Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Nov 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ASP-001 in Peripheral Arterial Disease (PAD), sponsored by Centre Hospitalier Universitaire d'Angers. Started Nov 2016; status: completed.
02
Drugs
ASP-001
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02832570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02832570.